When it comes to promoting innovative ideas in the field of life sciences within Charité – Universitätsmedizin Berlin and its partner institutions, Stiftung Charité has been an important authority since its establishment in 2005. The private,…
It’s not difficult to come across start-ups and young companies in the capital region. Berlin-Brandenburg boasts a diverse and steadily growing start-up ecosystem. And financing options are just as diverse as this ecosystem, encompassing various…
Apply before February 20!
Researchers at the Max Delbrück Center have developed a fast, cost-effective blood-based tool that can identify and classify immune deficiencies with high accuracy. The approach, published in “Nature Communications,” could help address long-standing…
Medication errors represent one of the most underestimated risks in professional care. In Germany alone, an estimated 250,000 hospital admissions occur annually due to incorrect medication, resulting in costs of up to €1 billion per year. Behind…
Dr. Sievert Weiss is a physician, co-founder, and medical director of AMBOSS. Since its founding, he and an interdisciplinary team have pursued the goal of making medical knowledge available where it is needed in everyday clinical practice.
For more than 20 years, JPT Peptide Technologies has been producing peptides for scientific purposes and the pharmaceutical industry in Berlin. In the year 2009, the biotech company was acquired by Mainz-based BioNTech SE and has since grown…
In the study, [68Ga]Ga-Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity for identifying unilateral aldosterone-producing adenomas compared with adrenal vein sampling (AVS) and surgical outcomes
The…
Apply now until March 3, 2026!
Europe's leading digital health platform closes Series D round to expand access to chronic care, led by long-term, impact-focused healthcare investors.
